Table 3.
Refs. | Inflammatory Model | Intervention Methods | Acupoints | Acupuncture Parameters | Inflammation-Related Behaviors | Test Sites | Biochemical Measurements |
---|---|---|---|---|---|---|---|
Feng, 202035 | ARDS | EA pre-treatment | LI4 | 2/100 Hz, 4.0 mA, 45 min | — | Lung tissues, serum, BALF | TNF-α↓, IL-1β↓, IL-6↓, MPO↓, PPARγ↑, MDA↓, SOD↑, GSH↑, Bax↓, Bcl-2↑, p-p65↓, p-IκBα↓, IκBα↑, PaO2↑ |
Lou, 202036 | ALI | EA pre-treatment | ST36, SP6 | 2/15 Hz, 1.0 mA, dispersed waves, 30 min | Lung injury scores | Lung tissues | TNF-α↓, IL-1↓, IL-6↓, MPO↓, TLR4↓, p‐NF‐κB↓ |
Gong, 202037 | ALI | EA | BL13, ST36 | 2/15Hz, 1.0 mA, disperse-dense wave, 15 min, 5 days | — | BALF, lung tissues, plasma | Nrf2↑, HO-1↑, p-p38/p38↑, SOD↑, GPX↑, CAT↑, MDA↓, Nrf2↑, HO-1↑ |
Huang, 201938 | CPB | EA pre-treatment | BL13, ST36 | 2/15 Hz, 30 min | — | Lung tissues, serum, BALF | NLRP3↓, IL-1β↓ |
Dhar, 201939 | CPB | EA pre-treatment | PC6, LI4 | 30 min | — | Lung tissues, serum | TNF-α↓, IL-18↓, IL-1β↓, NLRP3↓, Caspase-1↓, Caspase-8↓, p-Nrf2↓, MDA↓, SOD↑ |
Ma, 201740 | CPB | EA pre-treatment | PC6, LI4 | 2/100 Hz, 0.5 ms pulse width, 30 min | — | Lung tissues | MPO↓, MDA↓, SOD↑, Caspase-3↓, p-p38/p38↓ |
Li, 201542 | COPD | MA | BL13, BL23, Dingchuan | Twisted through 360°, 1 min every 5 min, 6 times | Pulmonary function (IC, PEF, MV) | Lung tissues, BALF | TNF-α↓, IL-8↓, HDAC2↑ |
Dong, 201944 | Asthma | MA | GV14, BL12, BL13 | 30 min | Airway resistance, lung dynamic compliance | Lung tissues, serum | IL-10↑, IL-5↓, IL-13↓, IL-17↓, CD4+ IL-17A+↓, CD4+ Foxp3+↑, p-p38↓, p-p44/42↓ |
Zhou, 201945 | Chronic sinusitis | EA | ST36, BL13, GV29, LI4 | 30 min, 10 days | — | Nasal tissues | IFN‑γ↑, IL‑10↑ |
Dong, 201846 | Asthma | MA | GV14, BL12, BL13 | Manual manipulations every 10 min in 30 min | Airway resistance, lung dynamic compliance | Lung tissues, serum, BALF | TNF-α↓, IL-1β↓, IL-33↓, sST2↑, CD4+IL-17A+↓, CD4+Foxp3+↑ |
Cui, 202048 | Asthma | MA | GV14, BL12, BL13 | Twisted 360°, 60 times/min, 5 times, 20 min | — | Serum, BALF | IL-5↓, IL-9↓, IL-13↓, IL-25↓, IL-33↓, sST2↑ |
Nurwati, 201849 | Asthma | MA | BL13, ST36 | 15 min, 3 times/week, 6 weeks from 21st day after modeling | — | Peripheral blood | neutrophil↓, eosinophil↓ |
Notes: ↑, upregulated by acupuncture; ↓, downregulated by acupuncture.
Abbreviations: ARDS, acute respiratory distress syndrome; ALI, acute lung injury; CPB, cardiopulmonary bypass; COPD, chronic obstructive pulmonary disease; IC, inspiratory capacity; PEF, peak expiratory flow; MV, minute volume; BALF, bronchoalveolar lavage fluid; PPARγ, peroxisome proliferator-activated receptor γ; glutathione peroxidase; GPX, GSH, glutathione; HDAC2, histone deacetylase 2; sST2, soluble growth-stimulating expression gene 2 protein; BL13, Feishu; PC6, Neiguan; BL23, Shenshu; GV14, Dazhui; BL12, Fengmen; GV29, Yingxiang.